|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total restricted cash | ||||||||||||||||||||
| Investment banking fees receivable | ||||||||||||||||||||
| Marketable securities owned at fair value (includes $2,863 and $5,696 pledged as collateral at September 30, 2021 and December 31, 2020, respectively) | ||||||||||||||||||||
| Other investments (includes $13,563 and $17,611 measured at fair value at September 30, 2021 and December 31, 2020, respectively) | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total other investments (includes $13,563 and $17,611 measured at fair value at September 30, 2021 and December 31, 2020, respectively) | ||||||||||||||||||||
| Loans held for investment, net of allowance for loan losses | ||||||||||||||||||||
| Total loans held for investment, net of allowance for loan losses | ||||||||||||||||||||
| Loans collateralizing asset-backed securities issued, net of allowance for loan losses | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total loans collateralizing asset-backed securities issued, net of allowance for loan losses | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total interest receivable | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Incentive fees receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Marketable securities sold, but not yet purchased, at fair value | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Asset-backed securities issued (net of debt issuance costs of $8,979 at December 31, 2018) | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total asset-backed securities issued (net of debt issuance costs of $8,979 at December 31, 2018) | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total interest payable | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| CLO warehouse credit facilities | ||||||||||||||||||||
| Bond payable (net of debt issuance costs of $1,400 and $2,953 at September 30, 2021 and December 31, 2020, respectively) | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total other liabilities | ||||||||||||||||||||
| Variable Interest Entity (VIE) or Potential VIE, Information Unavailability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| JMP Group LLC Shareholders' Equity | ||||||||||||||||||||
| Common shares, $0.001 par value, 100,000,000 shares authorized at September 30, 2021 and December 31, 2020; 22,797,092 shares issued at September 30, 2021 and December 31, 2020; 19,944,177 and 19,789,821 shares outstanding at September 30, 2021 and December 31, 2020, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury shares at cost, 2,852,915 and 3,007,271 shares at September 30, 2021 and December 31, 2020, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total JMP Group LLC shareholders' equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...